Literature DB >> 9473210

Control of vascular smooth muscle and endothelial cell proliferation and its implication in cardiovascular disease.

I Spyridopoulos1, V Andrés.   

Abstract

At homeostasis, endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in the arterial wall are fully differentiated and display a very low proliferative index. However, unlike terminally differentiated cells, mature ECs and VSMCs maintain their ability to dedifferentiate and reenter the cell cycle in response to several environmental stimuli. Because of the contribution of EC and VSMC proliferation to the pathogenesis of several diseases, including cancer and cardiovascular disease, considerable effort has been devoted to elucidate the mechanisms that regulate cell cycle progression in these cell types. These regulatory networks and the implications they may have for cardiovascular disease are reviewed here.

Entities:  

Mesh:

Year:  1998        PMID: 9473210     DOI: 10.2741/a240

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  4 in total

1.  Overexpression of catalase delays G0/G1- to S-phase transition during cell cycle progression in mouse aortic endothelial cells.

Authors:  Ogbeyalu E Onumah; George E Jules; Yanfeng Zhao; LiChun Zhou; Hong Yang; ZhongMao Guo
Journal:  Free Radic Biol Med       Date:  2009-03-31       Impact factor: 7.376

2.  Parthenolide inhibits proliferation of vascular smooth muscle cells through induction of G0/G1 phase cell cycle arrest.

Authors:  Shao-Xiang Weng; Mei-Hua Sui; Shan Chen; Jian-An Wang; Geng Xu; Ji Ma; Jiang Shan; Lu Fang
Journal:  J Zhejiang Univ Sci B       Date:  2009-07       Impact factor: 3.066

3.  Method for in vitro differentiation of bone marrow mesenchymal stem cells into endothelial progenitor cells and vascular endothelial cells.

Authors:  Qihong Wang; Weifeng Zhang; Guifen He; Huifang Sha; Zhe Quan
Journal:  Mol Med Rep       Date:  2016-11-18       Impact factor: 2.952

4.  Renal denervation attenuates aldosterone expression and associated cardiovascular pathophysiology in angiotensin II-induced hypertension.

Authors:  Mo-Na Hong; Xiao-Dong Li; Dong-Rui Chen; Cheng-Chao Ruan; Jian-Zhong Xu; Jing Chen; Yong-Jie Wu; Yu Ma; Ding-Liang Zhu; Ping-Jin Gao
Journal:  Oncotarget       Date:  2016-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.